Gazyva, Imfinzi Launched Following Japan Listing, Entyvio In The Wings

Japan has granted reimbursement prices to two anticancer antibodies and other products as it supports the availability of new, higher priced therapies in areas of high medical need, including through early access, while Takeda’s Entyvio is also set for launch.